Is the incidence of lymph node metastases increased with sentinel lymph node dissection in prostate cancer?;Wird die inzidenz von lymphknotenmetastasen durch sentinel-lymphknoten- dissektion beim prostatakarzinom erhöht?

Journal fur Urologie und Urogynakologie

Volumn 13, Issue 2, 2006, Pages 11-14

  Schafhauser, W ^a   Becher, H ^a   Schaffhauser, R ^a   Sachs, M ^b  

^a Klinikum Fichtelgebirge   (Germany)

^b Gemeinschaftspraxis für Pathologie ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM 99M;

AGED; ARTICLE; HUMAN; INCIDENCE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; PROSTATE CARCINOMA; PROSTATECTOMY;

EID: 33745322371     PISSN: 10236090     EISSN: 16809424     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Heidenreich A, Varga Z, von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: High incidence of lymph node metastasis. J Urol 2002; 167: 1681-6.
2. Clark T, Parekh DJ, Cookson MS, Chang SS, Smith ER Jr, Wells N, Smith JA Jr. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 2003; 169: 145-7.
3. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39: 456-66.
4. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK. Technical details of intraoperative mapping for early stage melanoma. Arch Surg 1992; 127: 392-8.
5. Bilchik AJ, Giuliano AE, Essner R, Bostick P, Kelemen P, Foshag LJ, Sostrin S, Turner RR, Morton DL. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am 1998; 4: 351-8.
6. Wawroschek F, Vogt H, Weckermann D, Wagner T, Hamm M, Harzmann R. Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol 2001; 166: 1715-9.
7. Wawroschek F, Wagner T, Hamm M, Weckermann D, Vogt H, Merkl B, Gordijn R, Harzmann R. The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node status in clinically localized prostate cancer. Eur Urol 2003; 43: 132-6.
8. Gardiner RA, Fitzpatrick JM, Constable AR, Cranage RW, O'Donoghue EP, Wickham JE. Improved techniques in radionuclide imaging of prostatic lymph nodes. Br J Urol 1979; 51: 561-4.
9. Wawroschek F, Vogt H, Wengenmair H, Weckermann D, Hamm M, Keil F, Graf G, Heidenreich P, Harzmann R. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int 2003; 70: 303-10.
10. Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol 2004; 172: 910-4.
11. Moul JW, Wu H, Sun L, McLeod DG, Amling C, Donahue T, Kusuda L, Sexton W, O'Reilly K, Hernandez J, Chung A, Soderdahl D. Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy. J Urol 2004; 171: 1141-7.
12. Weckermann D, Wawroschek F, Harzmann R. Is there a need for pelvic lymph node dissection in low risk prostate cancer patients prior to definitive local therapy. Eur Urol 2005; 47: 45-50.
13. Takashima H, Egawa M, Imao T, Fukuda M, YokoYama K, Namiki M. Validy of sentinel lymph node concept for patients with prostate cancer. J Urol 2004; 171: 2268-71.